Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

Presentation ACC 2023

Transcatheter vs Surgical Aortic Valve Replacement in Low RiskPatients: 3-Year Outcomes from the EvolutLow Risk Trial

Presenter: John K. Forrest

March 05, 2023

Presentation TVT 2020

Transcatheter Aortic Valve Replacement using an Evolut PRO Bioprosthesis in Low Risk Patients with Aortic Stenosis

Presenter: Bruce Rutkin

June 20, 2020

Presentation CACI 2019

TAVI in Low Risk Patients

Presenter: Fayaz Shawl

November 29, 2019

Presentation CACI 2019

¿Es posible tratar bajo riesgo en Argentina?

Presenter: Daniel Berrocal

November 29, 2019

Presentation Cardiovascular Interventions 2019

Show me the Data: Key Clinical Trials of 2019

Presenter: Ehtisham Mahmud

November 01, 2019

Presentation TCT Abstracts Posters 2019

Transcatheter Aortic Valve Replacement in Low-risk Patients A Meta-analysis of Randomized Controlled Trials

Presenter: Ahmad Al-Abdouh

October 06, 2019

Presentation TCT Abstracts Posters 2019

Distribution of coronary artery disease in patients with low-risk transcatheter aortic valve replacement: A computed tomography coronary angiography study (from the LRT trial)

Presenter: Yuichi Ozaki

September 29, 2019

Presentation SIF 2019

My Prediction on TAVR in Low Risk Patients

Presenter: Kendra J. Grubb

March 30, 2019

Presentation ACC 2019

Primary Results From the Evolut Low Risk Trial

Presenter: Michael J. Reardon

March 17, 2019

Presentation CRT 2019

Transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis

Presenter: Ron Waksman

March 05, 2019

Presentation

Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Low Risk

February 06, 2019

Bioprosthetic structural valve degeneration

Presentation CDM 2018

TAVR is Here to Stay: What About TAVR in Low-Risk Patients?

Presenter: Joseph P. Carrozza

October 12, 2018

Presentation CRT 2018

Transcatheter Aortic Valve Replacement for Patients with Severe Aortic Stenosis who are at Low Risk For Mortality: Interim results from the Prospective Multicenter LRT Clinical Trial

Presenter: Ron Waksman

March 04, 2018

Presentation TVT 2017

SURTAVI Vignette II: Subset Analysis of Patients With STS < 3% (Lower-Risk Patients)

Presenter: David J. Cohen, Jeffrey J. Popma

June 16, 2017

Presentation SIF 2017

TAVR Will Be Default in Low Risk Patients

Presenter: David L. Brown

March 11, 2017

Presentation TVT 2016

Study Design for the PARTNER 3 Low-Risk Trial

Presenter: Martin B. Leon

June 16, 2016

Presentation TVT 2016

Study Design for the EVOLUT R Low-Risk Trial

Presenter: Jeffrey J. Popma

June 16, 2016

Presentation TVT 2016

The Relentless Journey of TAVR to Lower-Risk Patients: Are We There Yet?

Presenter: Martin B. Leon

June 16, 2016

Presentation SOLACI 2016

Future Directions in TAVR: From Moderate-Low Risk Patients to New Devices

Presenter: Martin B. Leon

June 10, 2016

Presentation

TAVR Compared with SAVR in Low-Risk Patients

Presenter: Stefano Rosato

May 16, 2016

Advertisement

Transcatheter vs Surgical Aortic Valve Replacement in Low RiskPatients: 3-Year Outcomes from the EvolutLow Risk Trial

Transcatheter Aortic Valve Replacement using an Evolut PRO Bioprosthesis in Low Risk Patients with Aortic Stenosis

TAVI in Low Risk Patients

¿Es posible tratar bajo riesgo en Argentina?

Show me the Data: Key Clinical Trials of 2019

Transcatheter Aortic Valve Replacement in Low-risk Patients A Meta-analysis of Randomized Controlled Trials

Distribution of coronary artery disease in patients with low-risk transcatheter aortic valve replacement: A computed tomography coronary angiography study (from the LRT trial)

My Prediction on TAVR in Low Risk Patients

Primary Results From the Evolut Low Risk Trial

Transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis

Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Low Risk

TAVR is Here to Stay: What About TAVR in Low-Risk Patients?

Transcatheter Aortic Valve Replacement for Patients with Severe Aortic Stenosis who are at Low Risk For Mortality: Interim results from the Prospective Multicenter LRT Clinical Trial

SURTAVI Vignette II: Subset Analysis of Patients With STS < 3% (Lower-Risk Patients)

TAVR Will Be Default in Low Risk Patients

Study Design for the PARTNER 3 Low-Risk Trial

Study Design for the EVOLUT R Low-Risk Trial

The Relentless Journey of TAVR to Lower-Risk Patients: Are We There Yet?

Future Directions in TAVR: From Moderate-Low Risk Patients to New Devices

TAVR Compared with SAVR in Low-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content